Erratum: Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (Human Reproduction (2018) 33 (1602-1618) DOI: 10.1016/j.fertnstert.2018.05.004)

Abstract

The journal, Human Reproduction, would like to apologise for an error under the sub-section Biochemical hyperandrogenism of Table III in the above article. The following statement: Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time. Should read: Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for 3 months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time. The electronic version of this article has been updated at https:// doi.org/10.1093/humrep/dey256. The Journal would like to assure readers that this does not affect any other content of the article.